会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Method for the therapeutic management of endometriosis
    • 子宫内膜异位症治疗方法
    • US07666836B2
    • 2010-02-23
    • US11311363
    • 2005-12-20
    • Hilde Riethmuller-WinzenJurgen EngelRicardo FelberbaumKlaus DiedrichKupker Wolfgang
    • Hilde Riethmuller-WinzenJurgen EngelRicardo FelberbaumKlaus DiedrichKupker Wolfgang
    • A61K38/00A61K31/497A61K31/519A61K31/505
    • A61K38/08A61K45/06A61K2300/00
    • The present inventions provides a method for therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction by short term induction treatment with an LH-RH antagonist for 4 to 12 weeks. According to another aspect of the present invention, the short term LH-RH treatment is followed by the combined or separate administration of one or more active agents selected from the group consisting of a contraceptive, preferably an oral contraceptive, a non-steroidal anti-rheumatic agent, an analgetic, an androgen other than a 17-alpha-alkyl substituted testosterone or any combinations thereof. According to a further aspect of the present invention a pharmaceutical composition comprising an LHRH antagonist and one ore more active agents selected from the group consisting of a contraceptive, preferably an oral contraceptive, a non-steroidal anti-rheumatic agent, an analgetic, an androgen other than a 17-alpha-alkyl substituted testosterone or any combinations thereof are provided.
    • 本发明提供了一种通过LH-RH拮抗剂短期诱导治疗4至12周来治疗子宫内膜组织宫外增生,慢性盆腔疼痛和输卵管阻塞的方法。 根据本发明的另一方面,短期LH-RH治疗之后是联合或分开施用一种或多种活性剂,所述活性剂选自避孕药,优选口服避孕药,非类固醇抗生素, 风湿药,止痛剂,除17-α-烷基取代的睾酮以外的雄激素或其任何组合。 根据本发明的另一方面,包含LHRH拮抗剂和一种或多种选自避孕药,优选口服避孕药,非甾体抗风湿药,止痛剂,雄激素的活性剂的药物组合物 提供除17-α-烷基取代的睾酮或其任何组合以外的物质。
    • 2. 发明申请
    • METHOD FOR THE THERAPEUTIC MANAGEMENT OF ENDOMETRIOSIS
    • 内分泌治疗方法
    • US20080255053A1
    • 2008-10-16
    • US12099091
    • 2008-04-07
    • Hilde RIETHMULLER-WINZENJurgen EngelRicardo FelberbaumKlaus DiedrichKupker Wolfgang
    • Hilde RIETHMULLER-WINZENJurgen EngelRicardo FelberbaumKlaus DiedrichKupker Wolfgang
    • A61K38/08
    • A61K38/08A61K45/06A61K2300/00
    • The present inventions provides a method for therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction by short term induction treatment with an LH-RH antagonist for 4 to 12 weeks. According to another aspect of the present invention, the short term LH-RH treatment is followed by the combined or separate administration of one or more active agents selected from the group consisting of a contraceptive, preferably an oral contraceptive, a non-steroidal anti-rheumatic agent, an analgetic, an androgen other than a 17-alpha-alkyl substituted testosterone or any combinations thereof. According to a further aspect of the present invention a pharmaceutical composition comprising an LHRH antagonist and one ore more active agents selected from the group consisting of a contraceptive, preferably an oral contraceptive, a non-steroidal anti-rheumatic agent, an analgetic, an androgen other than a 17-alpha-alkyl substituted testosterone or any combinations thereof are provided.
    • 本发明提供了一种通过LH-RH拮抗剂短期诱导治疗4至12周来治疗子宫内膜组织宫外增生,慢性盆腔疼痛和输卵管阻塞的方法。 根据本发明的另一方面,短期LH-RH治疗之后是联合或分开施用一种或多种活性剂,所述活性剂选自避孕药,优选口服避孕药,非类固醇抗生素, 风湿药,止痛剂,除17-α-烷基取代的睾酮以外的雄激素或其任何组合。 根据本发明的另一方面,包含LHRH拮抗剂和一种或多种选自避孕药,优选口服避孕药,非甾体抗风湿药,止痛剂,雄激素的活性剂的药物组合物 提供除17-α-烷基取代的睾酮或其任何组合以外的物质。